Current CA-125 thresholds may miss ovarian cancer in racially diverse patients, delaying treatment initiation and contributing to health disparities. Original CA-125 studies were conducted on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback